HIBERGEN
DEAD

Serial Number

76270173

Owner

HiberGen Limited

Attorney

Robert J. Kenney

Filing Date

Jun 13, 2001

Add to watchlist:

No watchlists yet
View on USPTO

HIBERGEN Trademark

Serial Number: 76270173

HIBERGEN is a trademark filed by HiberGen Limited on June 13, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

HiberGen Limited (2 trademarks)

IDA Business Park
County Wicklow , IE

Entity Type: 03

Trademark Details

Filing Date

June 13, 2001

Registration Date

Not Registered

Published for Opposition

May 20, 2003

Goods & Services

Analytical and diagnostic kits comprising buffers, chemical reagents, fluorescent compounds, fluorescent-labelled compounds, nucleotides, nucleic acids, oligonucleotides all for use in medical diagnosis and testing of clinical samples; pharmaceutical preparations and substances for the treatment of complex diseases, namely, heat disease, psychiatric disorders, diabetes, inflammatory diseases, osteoporosis, arthritis, pre-eclampsia, pulmonary diseases and cancer; preparations for use in medical analysis, diagnosis and research, namely, microarrays, macroarrrays of nucleotides, nucleic acids and olingnucleotides applied to plastic chips, subrates and supports optionally also carrying buffers, chemical reagents, florescent compounds, florescent-labelled compounds all for use in medical diagnosis and testing of clinical samples

Preparations for use in medical analysis, diagnosis and research, namely, microarrays of nucleotides, nucleic acids and olignucleotides applied to plastic chips, substrates and supports optionally also carrying buffers, chemical reagents, flourescents compounds, florescent-labelled compounds all for use in medical research, pharmaceutical research, veterinary research, genotyping, detection of mutation and polymorphisms, the determination of the genetic basis of disease, the determination of the genetic basis of drug response, and the analysis, characterization and identification of nucleic acids; analytical and diagnostic kits comprising buffers, chemical reagents, florescent compounds, florescent-labelled compounds, nucleotides, nucleic acids, oligonucleotides all for use in medical research, pharmaceutical research, veterinary research, genotyping, detection of mutations and polymorphisms, the determination of genetic basis of drug response, and the analysis, characterization and identification of nucleic acids

Medical diagnosis, testing of clinical samples, medical research, detection of pathogens, identification of pathogens, diagnosis of disease, diagnosis of infection, veterinary research, genotyping, detection of mutations and polymorphisms, gene expression profiling, determination of the genetic basis of disease, determination of the genetic basis of drug response, nucleic acid analysis, nucleic acid characterization, nucleic acid identification, plant research, and human genome analysis; providing a genetic database

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Jun 7, 2004 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 12, 2003 NOAM
PUBLISHED FOR OPPOSITION
May 20, 2003 PUBO
NOTICE OF PUBLICATION
Apr 30, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2003 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 13, 2003 JURT
EX PARTE APPEAL-INSTITUTED
Feb 13, 2003 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Feb 11, 2003 EXAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 31, 2002 CRFA
PAPER RECEIVED
Dec 31, 2002 MAIL
ASSIGNED TO EXAMINER
Sep 12, 2002 DOCK
FINAL REFUSAL MAILED
Jul 29, 2002 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2002 CRFA
NON-FINAL ACTION MAILED
Jan 31, 2002 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2001 CRFA
NON-FINAL ACTION MAILED
Aug 21, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2001 DOCK